A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Stronium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dexamethasone; Docetaxel; Doxorubicin; Estramustine; Estramustine phosphate sodium; Ketoconazole; Prednisone; Strontium-89; Vinblastine
- Indications Prostate cancer
- Focus Therapeutic Use
- 22 Mar 2016 Biomarkers information updated
- 27 Jun 2013 Planned end date changed from 1 May 2013 to 1 May 2015 as reported by ClinicalTrials.gov.
- 15 Jun 2012 Planned end date changed from 1 Oct 2014 to 1 May 2013 as reported by ClinicalTrials.gov.